Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

32results about How to "Mild elution conditions" patented technology

Performance improved recombination staphylococcus aureus protein A affinity ligand and construction method thereof

The present invention discloses a performance improved recombination staphylococcus aureus protein A affinity ligand and a construction method thereof. The present invention adopts a molecular biology method. A sequence B of a nature protein A is selected for molecular transformation. A C-terminal of the sequence B is added with two cysteines, so that the protein A can pass through double-locus coupled chromatography matrix to stabilize the connection. Six glycines are added to the end of a second Loop of the sequence B to increase the length and reduce the binding force with an antibody, so that elution conditions are mild. On this basis, resistance performance to high concentration base of the protein A is transformed. Asparagines and phenylalanine at 23rd and 30th positions of the sequence B are respectively replaced by threonine and alanine to obtain a sequence Z with higher alkaline resistance properties. Then, isocaudarner is used for connecting sequence Zs of different numbers head-to-tail in series. The efficient expression system of e. coli is used for overexpression. The expressed recombination protein A is coupled to agarose matrix preparation affinity chromatography fillers and is used for purifying antibodies. Results show that the recombination protein A affinity ligand prepared by the present invention is good in elution performance and alkali resistance.
Owner:嘉兴千纯生物科技有限公司

Method for separating human serum albumin by expanded bed adsorption based on mixed mode

The invention discloses a method for adsorbing and separating human serum albumin by expanded bed adsorption based on a mixed mode, which can directly separate and recombine human serum albumin from a yeast fermentation solution, and belongs to the protein separation technology in the biochemical field. The method comprises the following steps: (1) preprocessing a fermentation solution; obtaining the yeast fermentation solution containing the human serum albumin, adding sodium caprylate, and heating and deactivating protease; (2) performing expanded bed adsorption, directly separating the yeast fermentation solution by using an expanded bed filled with a mixed-mode adsorption agent, and collecting elution peaks; and (3) desalting and drying: desalting a collected solution, freeze drying to obtain the human serum albumin with the purity greater than 95 percent. The invention is characterized by developing a novel separation process, so that the high-purity recombined human serum albumin can be directly separated from the yeast fermentation solution. A critical point of the invention lies in adopting the expanded bed adsorption agent based on the mixed mode, cells do not need to be removed from the yeast fermentation solution, the ion strength does not need to be adjusted, the elution condition is moderate, and the method has the characteristics of simple process, high separation efficiency and high yield.
Owner:ZHEJIANG UNIV

Post-extraction process for swine alpha-interferon

The invention relates to a post-extraction process for swine alpha-interferon and belongs to the technical field of production of drugs for livestock and poultry. The process comprises the steps: S1.subjecting swine alpha-interferon containing fermentation broth to centrifugation, and reserving supernatant; S2. filtering the supernatant through a 50KDa ceramic membrane, then, filtering filter liquor through a 10KDa ceramic membrane, and collecting trapped fluid; S3. adding an equal volume of Ni<2+>-IDA-glucan vector and a NaCl solution into the trapped fluid obtained in the step S2, and carrying out an adsorption reaction, so as to obtain a reaction solution; S4. adding an equal volume of phosphate buffer solution into the reaction solution obtained in the step S3, carrying out uniform mixing, then, carrying out filtering through a 50KDa ceramic membrane, and collecting trapped fluid; S5. adding an eluent into the trapped fluid obtained in the step S4, then, carrying out filtering through a 30KDa ceramic membrane, and collecting filter liquor; and S6. filtering the filter liquor obtained in the step S5 through a 10KDa ceramic membrane to remove salts, and collecting trapped fluid,thereby obtaining the swine alpha-interferon. According to the process, the yield is 62% or more, the purity is 98% or more, and the active yield is 100%.
Owner:山东仙普爱瑞科技股份有限公司

A performance-improved recombinant Staphylococcus aureus protein a affinity ligand and its construction method

The present invention discloses a performance improved recombination staphylococcus aureus protein A affinity ligand and a construction method thereof. The present invention adopts a molecular biology method. A sequence B of a nature protein A is selected for molecular transformation. A C-terminal of the sequence B is added with two cysteines, so that the protein A can pass through double-locus coupled chromatography matrix to stabilize the connection. Six glycines are added to the end of a second Loop of the sequence B to increase the length and reduce the binding force with an antibody, so that elution conditions are mild. On this basis, resistance performance to high concentration base of the protein A is transformed. Asparagines and phenylalanine at 23rd and 30th positions of the sequence B are respectively replaced by threonine and alanine to obtain a sequence Z with higher alkaline resistance properties. Then, isocaudarner is used for connecting sequence Zs of different numbers head-to-tail in series. The efficient expression system of e. coli is used for overexpression. The expressed recombination protein A is coupled to agarose matrix preparation affinity chromatography fillers and is used for purifying antibodies. Results show that the recombination protein A affinity ligand prepared by the present invention is good in elution performance and alkali resistance.
Owner:嘉兴千纯生物科技有限公司

A Mixed Mode Based Expanded Bed Adsorption Method for Separation of Human Serum Albumin

The invention discloses a method for adsorbing and separating human serum albumin by expanded bed adsorption based on a mixed mode, which can directly separate and recombine human serum albumin from a yeast fermentation solution, and belongs to the protein separation technology in the biochemical field. The method comprises the following steps: (1) preprocessing a fermentation solution; obtaining the yeast fermentation solution containing the human serum albumin, adding sodium caprylate, and heating and deactivating protease; (2) performing expanded bed adsorption, directly separating the yeast fermentation solution by using an expanded bed filled with a mixed-mode adsorption agent, and collecting elution peaks; and (3) desalting and drying: desalting a collected solution, freeze drying to obtain the human serum albumin with the purity greater than 95 percent. The invention is characterized by developing a novel separation process, so that the high-purity recombined human serum albumin can be directly separated from the yeast fermentation solution. A critical point of the invention lies in adopting the expanded bed adsorption agent based on the mixed mode, cells do not need to be removed from the yeast fermentation solution, the ion strength does not need to be adjusted, the elution condition is moderate, and the method has the characteristics of simple process, high separation efficiency and high yield.
Owner:ZHEJIANG UNIV

A mixed-mode chromatographic method for separating human albumin from yeast fermentation broth

The invention belongs to the protein chromatographic separation technology in the field of biochemical industry and discloses a mixed model chromatographic method for separating human serum albumin from yeast fermentation liquid. The method includes steps: 1) fermentation liquid pretreatment, to be more specific, removing yeast cells by centrifuging the yeast fermentation liquid which contains the human serum albumin, adding sodium caprylate, heating to remove impurity proteins and inactivating protease, performing centrifugal separation, and taking supernatant; 2) column chromatography, to be more specific, adopting a mixed mode medium with tryptophan as ligand, performing fixed bed chromatographic separation of the supernatant, and collecting elution peaks, wherein a sample loading pH value is 4.0-4.5, and an elution pH value is 7.0-9.0; 3) desalting and drying, desalting collected liquid, performing freeze drying to obtain the human serum albumin with purity larger than 95%. The mixed model chromatographic method is characterized in that by development of a novel separation process, the high-purity human serum albumin can be directly separated from the yeast fermentation liquid. By adoption of the mixed mode medium with tryptophan as the ligand, ion strength adjustment of the yeast fermentation liquid is avoided, adsorption under acid conditions and elution under neutral and weak alkali conditions are realized, and the method has advantages of mild elution conditions, simple process, high separation efficiency and high yield.
Owner:ZHEJIANG UNIV

Affinity chromatography medium with tetrapeptide as functional ligand and preparation method thereof

The invention discloses an affinity chromatography medium employing tetrapeptide as a functional ligand and a preparation method of the affinity chromatography medium. The method comprises the following steps: adding dry matrix and allyl bromide to a dimethyl sulfoxide solution, activating, and reacting activating matrix with N-bromo succinimide; enabling bromo alcoholized matrix to react with hexamethylendiamine to obtain amino activating matrix; sequentially washing with deionized water, absolute ethyl alcohol and anhydrous N,N-dimethyl formamide, adding an N,N-dimethyl formamide solution containing tetrapeptide, 2-(7-azobenzotriazole)-N,N,N',N'-te-tramethyluronium hexafluorophosphate and N,N-diisopropylethylamine, and coupling a tetrapeptide ligand; and putting a medium coupled to tetrapeptide in a mixed liquid of sodium acetate and acetic anhydride to obtain the affinity chromatography medium employing tetrapeptide as the functional ligand. According to the novel chromatography medium developed by the method, a functional group is tetrapeptide composed of tyrosine, phenylalanine, arginine and histidine, and is designed on the basis of a protein A binding site of an antibody Fc segment; the antibody binding selectivity is greatly improved; and the affinity chromatography medium can be applied to efficient separation of an antibody.
Owner:ZHEJIANG UNIV

Method for preparing microspheric PGDT separating medium with two kinds of pore forms

The invention discloses a preparation method of a microsphere PGDT separation medium with two types of pores. The method is to mix the monomer, cross-linking agent, liquid porogen, and initiator first, then add the solid porogen and mix evenly, and form microspheres through suspension polymerization, extract the microspheres with absolute ethanol, and pickle , and dry, two types of pore-type separation media can be obtained. It is characterized in that: the solid porogen is calcium carbonate, and the dosage accounts for 10-3% of the volume content of the reaction mixture; the volume ratio of the solid porogen to the liquid porogen is 0.5-1; the dosage of the porogen accounts for 3% of the volume content of the reaction mixture. 20-60%; the amount ratio of the two cross-linking agents is 0.5-2, and the ratio of the amount of cross-linking agent to the amount of monomer is 0.3-0.6; under normal pressure, the polymerization temperature is controlled at 65-85 between ℃. The separation medium prepared by the method can be used for the separation of biomacromolecules such as proteins after modification, has large adsorption capacity and mild elution conditions, and has good application prospects in large-scale preparative separation of biomacromolecules.
Owner:TIANJIN UNIV

A kind of biomimetic small peptide ligand-based affinity-enriched monolithic material and its preparation and application

The invention belongs to the field of affinity enrichment integral materials and discloses an affinity enrichment integral material based on biomimetic small peptide ligands, preparation and an application. A substrate integral material is prepared from monomer GMA, a crosslinking agent, a pore-foaming agent and an initiator through a mixed reaction; then a metal chelator solution is poured into the substrate material, a heating reaction is performed, then a metal inorganic salt solution is poured for a reaction, so that metal ions are chelated and immobilized to the substrate material, then ahistidine-tagged small peptide ligand solution is poured for a reaction, and the affinity enrichment integral material based on the biomimetic small peptide ligands is obtained. Small peptides are taken as affinity ligands of the integral material, compared with the commonly used biomacromolecular ligands such as protein A / G, antigens or target proteins and the like, the small peptides have the advantages of being low in cost, stable in chemical property, free of immunogenicity and long in service life and containing no biological impurities, and conformation of an antibody protein cannot bedamaged due to quite mild elution conditions.
Owner:JINAN UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products